Literature DB >> 28849254

Imaging characteristics of subcutaneous amyloid deposits in diabetic patients: the "insulin ball".

Noriko Tanio1, Taiki Nozaki2, Masaki Matsusako1, Jay Starkey1, Koyu Suzuki3.   

Abstract

OBJECTIVE: The purpose of this study was to describe the imaging characteristics of subcutaneous amyloid deposits occurring at sites of insulin injection, commonly known as "insulin balls," in diabetic patients on ultrasound, CT, and MRI with pathologic correlation.
MATERIALS AND METHODS: We retrospectively reviewed the radiographic findings of 14 lesions in 9 patients diagnosed with subcutaneous amyloid deposits at our institution between 2005-2015. Three board-certified radiologists analyzed the following: (1) the shape, size, margin, morphologic characteristics, and blood flow on US using the color Doppler signal, (2) shape, size, margin, attenuation, and presence or absence of contrast enhancement on CT, and (3) shape, size, margin, signal intensity, and presence or absence of contrast enhancement on MRI.
RESULTS: All lesions showed ill-defined hypovascular subcutaneous nodules with irregular margins. The median diameter of lesions was 50.4 mm on US, 46.8 mm on CT, and 51.4 mm on MRI. The internal echogenicity of subcutaneous amyloid deposits was hypoechoic and heterogeneous on US. All lesions showed isodensity compared to muscle with irregular margins and minimal contrast enhancement on CT. Both T1- and T2-weighted MR images showed low signal intensity compared with subcutaneous fat. Normal diffusion and minimal contrast enhancement were seen.
CONCLUSIONS: Subcutaneous amyloid deposits which cause insulin resistance are typically ill-defined and heterogeneous hypovascular subcutaneous nodules with irregular margins on imaging that correspond to insulin injection sites. It is also characteristic that T2WI shows low intensity compared with fat on MRI, reflective of the amyloid content.

Entities:  

Keywords:  CT; Imaging findings; MRI; Subcutaneous amyloid deposits; US

Mesh:

Substances:

Year:  2017        PMID: 28849254     DOI: 10.1007/s00256-017-2749-8

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  20 in total

1.  Color Doppler sonography of focal lesions of the skin and subcutaneous tissue.

Authors:  F Giovagnorio; C Andreoli; M L De Cicco
Journal:  J Ultrasound Med       Date:  1999-02       Impact factor: 2.153

2.  Examination of insulin injection sites: an unexpected finding of localized amyloidosis.

Authors:  B Swift
Journal:  Diabet Med       Date:  2002-10       Impact factor: 4.359

3.  Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation.

Authors:  Justin O Endo; Christoph Röcken; Sara Lamb; Ronald M Harris; Anneli R Bowen
Journal:  J Am Acad Dermatol       Date:  2010-12       Impact factor: 11.527

Review 4.  Dialysis-related amyloidosis revisited.

Authors:  Emilia Kiss; Gèrald Keusch; Marco Zanetti; Tarzis Jung; Albin Schwarz; Michael Schocke; Werner Jaschke; Benedikt V Czermak
Journal:  AJR Am J Roentgenol       Date:  2005-12       Impact factor: 3.959

5.  The insulin ball.

Authors:  Terumasa Nagase; Yoshiya Katsura; Yoshiki Iwaki; Kenji Nemoto; Hidenori Sekine; Kazuhiro Miwa; Tsunao Oh-I; Keni Kou; Keiichi Iwaya; Masayuki Noritake; Takeshi Matsuoka
Journal:  Lancet       Date:  2009-01-10       Impact factor: 79.321

6.  Localized cutaneous amyloid at an insulin injection site.

Authors:  A A Lonsdale-Eccles; P Gonda; J A Gilbertson; A E Haworth
Journal:  Clin Exp Dermatol       Date:  2009-12       Impact factor: 3.470

7.  Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.

Authors:  P G McNally; N I Jowett; J J Kurinczuk; R W Peck; J R Hearnshaw
Journal:  Postgrad Med J       Date:  1988-11       Impact factor: 2.401

Review 8.  Localized amyloidosis at the site of repeated insulin injection in a diabetic patient.

Authors:  Yasuyoshi Shikama; Jun-Ichi Kitazawa; Nobuo Yagihashi; Osamu Uehara; Yuuji Murata; Nobuhisa Yajima; Ryuichi Wada; Soroku Yagihashi
Journal:  Intern Med       Date:  2010-03-01       Impact factor: 1.271

9.  Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report.

Authors:  Saniye Yumlu; Robert Barany; Magdalena Eriksson; Christoph Röcken
Journal:  Hum Pathol       Date:  2009-08-14       Impact factor: 3.466

10.  Investigation into the role of macrophages in the formation and degradation of beta2-microglobulin amyloid fibrils.

Authors:  Isobel J Morten; Walraj S Gosal; Sheena E Radford; Eric W Hewitt
Journal:  J Biol Chem       Date:  2007-08-08       Impact factor: 5.157

View more
  1 in total

1.  Impact of Insulin-Derived Amyloidosis on Glycemic Control and Insulin Dosing.

Authors:  Aaron Estep; Jarrod Uhrig; Curtis Bower; Robert Jarrett
Journal:  Clin Diabetes       Date:  2022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.